Read more about the article Albert Labs Chief Medical Officer on the MHRA’s new guidance on use of Real-world Data and Real-World Evidence in Clinical Trials

Albert Labs Chief Medical Officer on the MHRA’s new guidance on use of Real-world Data and Real-World Evidence in Clinical Trials

Albert Labs, today announced that it has received conditional approval for the listing of its common shares on the Canadian Securities Exchange ("CSE") in coordination with its previously announced transaction with ME Resource Corp ("MEC"). Subject to final CSE approval, the Common Shares of the Company are expected to commence trading on the CSE under the ticker "ABRT" early in the new year.

Continue ReadingAlbert Labs Chief Medical Officer on the MHRA’s new guidance on use of Real-world Data and Real-World Evidence in Clinical Trials
Read more about the article “The CSE listing will allow us to deliver promise of psychedelic therapy to cancer patients in need”

“The CSE listing will allow us to deliver promise of psychedelic therapy to cancer patients in need”

Albert Labs, today announced that it has received conditional approval for the listing of its common shares on the Canadian Securities Exchange ("CSE") in coordination with its previously announced transaction with ME Resource Corp ("MEC"). Subject to final CSE approval, the Common Shares of the Company are expected to commence trading on the CSE under the ticker "ABRT" early in the new year.

Continue Reading“The CSE listing will allow us to deliver promise of psychedelic therapy to cancer patients in need”